These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6282178)

  • 21. Characterization of paraoxonase activity in pericardial fluid: usefulness as a marker of coronary disease.
    Hernández AF; Pla A; Valenzuela A; Gil F; Villanueva E
    Chem Biol Interact; 1993 Jun; 87(1-3):173-7. PubMed ID: 8393740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular basis of the human serum paraoxonase activity polymorphism.
    Humbert R; Adler DA; Disteche CM; Hassett C; Omiecinski CJ; Furlong CE
    Nat Genet; 1993 Jan; 3(1):73-6. PubMed ID: 8098250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins.
    Saha N; Roy AC; Teo SH; Tay JS; Ratnam SS
    Clin Genet; 1991 Oct; 40(4):277-82. PubMed ID: 1661643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation in paraoxonase activity and sensitivity to diisopropylphosphofluoridate in inbred mice.
    Wehner JM; Murphy-Erdosh C; Smolen A; Smolen TN
    Pharmacol Biochem Behav; 1987 Oct; 28(2):317-20. PubMed ID: 2825223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraoxonase distribution in Caucasian males.
    Williams FM; Mutch E; Blain PG
    Chem Biol Interact; 1993 Jun; 87(1-3):155-60. PubMed ID: 8393737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polymorphism of human serum paraoxonase activity in childhood].
    Szabó I; Róna K; Czinner A; Gachályi B; Káldor A
    Orv Hetil; 1987 Mar; 128(12):631-3. PubMed ID: 3033577
    [No Abstract]   [Full Text] [Related]  

  • 27. Ecogenetic studies in Atacameño Indians.
    Goedde HW; Rothhammer F; Benkmann HG; Bogdanski P
    Hum Genet; 1984; 67(3):343-6. PubMed ID: 6088389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human serum "A"-esterases. Hydrolysis of O,O-dimethyl-2,2-dichlorovinyl phosphate.
    Traverso R; Moretto A; Lotti M
    Biochem Pharmacol; 1989 Feb; 38(4):671-6. PubMed ID: 2537085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the genetics of the human serum paraoxonase (EC 3.1.1.2).
    Geldmacher-v Mallinckrodt M; Hommel G; Dumbach J
    Hum Genet; 1979 Sep; 50(3):313-26. PubMed ID: 226468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoproteins and hydrolysis of organophosphorus compounds.
    Zech R; Röckseisen M; Kluge K; Dewald K; Armstrong VW; Chemnitius JM
    Chem Biol Interact; 1993 Jun; 87(1-3):85-94. PubMed ID: 8393751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of serum paraoxon hydrolyzing activity in family and population samples.
    Ishimoto G; Uchida H; Tsuge A
    Nihon Hoigaku Zasshi; 1987 Aug; 41(4):347-50. PubMed ID: 2826857
    [No Abstract]   [Full Text] [Related]  

  • 32. Paraoxonase phenotype distribution in Canadian Indian and Inuit populations.
    Carro-Ciampi G; Gray S; Kalow W
    Can J Physiol Pharmacol; 1983 Apr; 61(4):336-40. PubMed ID: 6305466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders.
    Pavković E; Simeon V; Reiner E; Sućić M; Lipovac V
    Chem Biol Interact; 1993 Jun; 87(1-3):179-82. PubMed ID: 8393741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence.
    Hassett C; Richter RJ; Humbert R; Chapline C; Crabb JW; Omiecinski CJ; Furlong CE
    Biochemistry; 1991 Oct; 30(42):10141-9. PubMed ID: 1657140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical significance of paraoxonase activity in a control group of children and a group of children of parents who had had early myocardial.
    Nisselbaum JS
    Clin Chem; 1987 Aug; 33(8):1496. PubMed ID: 3038380
    [No Abstract]   [Full Text] [Related]  

  • 36. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
    Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
    Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mathematical model for evaluating the reaction of paraoxon with human serum cholinesterase and with polymorphic forms of paraoxonase.
    Eckerson HW; La Du BN
    Drug Metab Dispos; 1984; 12(1):57-62. PubMed ID: 6141913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low A-esterase activity in serum of patients with fish-eye disease.
    Mackness MI; Walker CH; Carlson LA
    Clin Chem; 1987 Apr; 33(4):587-8. PubMed ID: 3030583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is paraoxonase related to atherosclerosis.
    Mackness MI; Arrol S; Abbott CA; Durrington PN
    Chem Biol Interact; 1993 Jun; 87(1-3):161-71. PubMed ID: 8393738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population, formal genetics, and linkage relations of the phosphoglycolate phosphatase (PGP)--E.C.3.1.3.18.
    Brink W; Baur MP; Rittner C
    Hum Genet; 1981; 59(4):386-8. PubMed ID: 6277765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.